Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Babici

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|September 25, 2003
[The place of mycophenolate mofetil in glomerular diseases]C Badid, D Babici, M Laville
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 30, 2003
[Target organ effects in untreated hypertension]D Babici, I M'Pio, A Hadj-Aïssa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 30, 2003
[Medical management of libido disturbances in treated hypertensive patients: differences between men and women]X Girerd, C Mounier-Vehier, J P Fauvel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 9, 2002
[Rational choice for second antihypertensive agent after failure of the first monotherapy: therapeutic strategy]X Girerd, O Hanon, D Babici, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|September 25, 2003
[The place of mycophenolate mofetil in glomerular diseases]C Badid, D Babici, M Laville
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 30, 2003
[Target organ effects in untreated hypertension]D Babici, I M'Pio, A Hadj-Aïssa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 30, 2003
[Medical management of libido disturbances in treated hypertensive patients: differences between men and women]X Girerd, C Mounier-Vehier, J P Fauvel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 9, 2002
[Rational choice for second antihypertensive agent after failure of the first monotherapy: therapeutic strategy]X Girerd, O Hanon, D Babici, et al.
Pageof 1